February 2026 saw robust M&A activity across the pharmaceutical and biotechnology sectors, marked by several high-value ...
Iranian biopharma CinnaGen has secured European marketing authorization for Zandoriah (teriparatide), a biosimilar to Forsteo ...
Pain management specialist Grünenthal today announced that it has acquired Kyowa Kirin’s 49% stake in ‘Grünenthal Meds’, ...
Chinese biotech Innovent Biologics (HKEX: 01801) has secured approval from China’s National Medical Products Administration ...
Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...
Chinese biotech Antengene (SEHK: 6996) has secured reimbursement in South Korea for Xpovio (selinexor) in combination with ...
Sweden's pharmaceutical exports increased by more than 1% to 154 billion Swedish kroner in 2025. These new trade statistics ...
US pharma giant Pfizer has withdrawn its European application for a marketing authorization of Zumrad (sasanlimab) for the ...
Canada-based clinical-stage biotech Zymeworks ) and Royalty Pharma today announced an agreement for $250 million in funding ...
Denmark’s pharmaceutical industry association Lif has called on politicians to make patient access to new medicines and the ...
February 2026 delivered significant signals across the rare disease ecosystem, spanning regulatory approvals, legislative ...
Indian drugmaker Aurobindo Pharma plans to scale up production of Penicillin-G to more than 10,000 metric tonnes annually within the next 12 months. The Hyderabad-based pharmaceutical company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results